Cargando…

C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT

Highly purified C'1 esterase of human serum is capable of inactivating isolated fourth component of human complement (β(1E)-globulin). Inactivation is accompanied by changes in electrophoretic and ultracentrifugal properties of β(1E)-globulin. If non-sensitized sheep erythrocytes are present du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller-Eberhard, Hans J., Lepow, Irwin H.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1965
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137997/ https://www.ncbi.nlm.nih.gov/pubmed/14280442

Ejemplares similares

SOME PROPERTIES OF AN ESTERASE DERIVED FROM PREPARATIONS OF THE FIRST COMPONENT OF COMPLEMENT
por: Ratnoff, Oscar D., et al.
Publicado: (1957)

COMPLEMENT AS A MEDIATOR OF INFLAMMATION : ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE
por: Ratnoff, Oscar D., et al.
Publicado: (1963)

THE SECOND COMPONENT OF HUMAN COMPLEMENT: ITS ISOLATION, FRAGMENTATION BY C'1 ESTERASE, AND INCORPORATION INTO C'3 CONVERTASE
por: Polley, Margaret J., et al.
Publicado: (1968)

ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT
por: Müller-Eberhard, H. J., et al.
Publicado: (1963)

STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE
por: Hinz, Carl F., et al.
Publicado: (1961)

COMPLEMENT AS A MEDIATOR OF INFLAMMATION : II. BIOLOGICAL PROPERTIES OF ANAPHYLATOXIN PREPARED WITH PURIFIED COMPONENTS OF HUMAN COMPLEMENT
por: da Silva, W. Dias, et al.
Publicado: (1967)

STUDIES ON IMMUNE CELLULAR INJURY : II. FUNCTIONAL ROLE OF C'1 ESTERASE IN IMMUNE CYTOTOXICITY
por: Lepow, Irwin H., et al.
Publicado: (1960)

COMPLEMENT AS A MEDIATOR OF INFLAMMATION : III. PURIFICATION OF THE ACTIVITY WITH ANAPHYLATOXIN PROPERTIES GENERATED BY INTERACTION OF THE FIRST FOUR COMPONENTS OF COMPLEMENT AND ITS IDENTIFICATION AS A CLEAVAGE PRODUCT OF C'3
por: da Silva, W. Dias, et al.
Publicado: (1967)

FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE
por: Schreiber, Robert D., et al.
Publicado: (1974)

THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT
por: Naff, George B., et al.
Publicado: (1964)

STUDIES ON THE ACTIVATION OF A PROESTERASE ASSOCIATED WITH PARTIALLY PURIFIED FIRST COMPONENT OF HUMAN COMPLEMENT
por: Lepow, Irwin H., et al.
Publicado: (1958)

THE INFLUENCE OF CALCIUM IONS ON THE INACTIVATION OF HUMAN COMPLEMENT AND ITS COMPONENTS BY PLASMIN
por: Lepow, Irwin H., et al.
Publicado: (1953)

FORMATION AND FUNCTIONAL SIGNIFICANCE OF A MOLECULAR COMPLEX DERIVED FROM THE SECOND AND THE FOURTH COMPONENT OF HUMAN COMPLEMENT
por: Müller-Eberhard, Hans J., et al.
Publicado: (1967)

THE INACTIVATION OF COMPLEMENT AND ITS COMPONENTS BY PLASMIN
por: Pillemer, Louis, et al.
Publicado: (1953)

DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE WITH AN INHERITED COMPLEMENT DEFECT
por: Nilsson, Ulf R., et al.
Publicado: (1967)

ENHANCEMENT OF THE HEMOLYTIC ACTIVITY OF THE SECOND COMPONENT OF HUMAN COMPLEMENT BY OXIDATION
por: Polley, Margaret J., et al.
Publicado: (1967)

CHROMATOGRAPHIC RESOLUTION OF THE FIRST COMPONENT OF HUMAN COMPLEMENT INTO THREE ACTIVITIES
por: Lepow, I. H., et al.
Publicado: (1963)

STUDIES ON IMMUNE CELLULAR INJURY : I. CYTOTOXIC EFFECTS OF ANTIBODY AND COMPLEMENT
por: Ross, Ann, et al.
Publicado: (1960)

THE EIGHTH COMPONENT OF HUMAN COMPLEMENT (C8): ISOLATION, CHARACTERIZATION, AND HEMOLYTIC EFFICIENCY
por: Manni, Jorge A., et al.
Publicado: (1969)

No prominent role for complement C1-esterase inhibitor in Marfan syndrome mice
por: Hibender, Stijntje, et al.
Publicado: (2022)

DEFICIENCY OF THE SIXTH COMPONENT OF COMPLEMENT IN RABBITS WITH AN INHERITED COMPLEMENT DEFECT
por: Rother, Klaus, et al.
Publicado: (1966)

THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
por: Götze, Otto, et al.
Publicado: (1971)

THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR
por: Ratnoff, Oscar D., et al.
Publicado: (1969)

THE PREPARATION AND PHYSICOCHEMICAL CHARACTERIZATION OF THE SERUM PROTEIN COMPONENTS OF COMPLEMENT
por: Pillemer, L., et al.
Publicado: (1941)

PRODUCTION OF ULTRASTRUCTURAL MEMBRANE LESIONS BY THE FIFTH COMPONENT OF COMPLEMENT
por: Polley, Margaret J., et al.
Publicado: (1971)

A BLOOD COAGULATION ABNORMALITY IN RABBITS DEFICIENT IN THE SIXTH COMPONENT OF COMPLEMENT (C6) AND ITS CORRECTION BY PURIFIED C6
por: Zimmerman, Theodore S., et al.
Publicado: (1971)

STUDIES ON IMMUNE HUMAN HEMOLYSIS : I. THE KINETICS OF THE DONATH-LANDSTEINER REACTION AND THE REQUIREMENT FOR COMPLEMENT IN THE REACTION
por: Hinz, Carl F., et al.
Publicado: (1961)

ISOLATION OF β(1F)-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT
por: Nilsson, Ulf R., et al.
Publicado: (1965)

THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENT
por: Cochrane, C. G., et al.
Publicado: (1968)

Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia
por: de Beer, Friso, et al.
Publicado: (2016)

THE REQUIREMENT OF SERINE ESTERASE FUNCTION IN COMPLEMENT-DEPENDENT ERYTHROPHAGOCYTOSIS
por: Pearlman, David S., et al.
Publicado: (1969)

ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM
por: Bokisch, Viktor A., et al.
Publicado: (1969)

RECEPTOR FOR THE FOURTH COMPONENT OF COMPLEMENT ON HUMAN B LYMPHOCYTES AND CULTURED HUMAN LYMPHOBLASTOID CELLS
por: Bokisch, Viktor A., et al.
Publicado: (1974)

Complement C1 Esterase Inhibitor Levels Linked to Infections and Contaminated Heparin-Associated Adverse Events
por: Zhou, Zhao-Hua, et al.
Publicado: (2012)

THE ROLE OF PROPERDIN IN THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
por: Götze, Otto, et al.
Publicado: (1974)

C1 esterase inhibitor in pediatric cardiac surgery with cardiopulmonary bypass plays a vital role in activation of the complement system
por: Miyamoto, Takashi, et al.
Publicado: (2019)

The murine H-2.7 specificity is an antigenic determinant of C4d, a fragment of the fourth component of the complement system
Publicado: (1980)

Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury
por: Wygrecka, Malgorzata, et al.
Publicado: (2022)

Genetic Association of the Porcine C9 Complement Component with Hemolytic Complement Activity
por: Khoa, D. V. A., et al.
Publicado: (2015)

PARTIAL BIOCHEMICAL CHARACTERIZATION OF THE ACTIVATED ESTERASE REQUIRED IN THE COMPLEMENT-DEPENDENT CHEMOTAXIS OF RABBIT POLYMORPHONUCLEAR LEUKOCYTES
por: Becker, Elmer L., et al.
Publicado: (1967)

Cannot write session to /tmp/vufind_sessions/sess_0i8go15fv8r44m9bnh6vvucqrk